YOLFTbeta
IM

Imexpharm Corp

IMP · VN · Healthcare / Drug Manufacturers - Specialty & Generic

34,750.00VND-750.00 (-2.11%)

Price History

Full chart

Market Stats

Previous Close35,500.00
Open34,300.00
Day Range34,250.00 – 34,750.00
52-Week Range32,650.00 – 56,169.90
Volume1.62K
Market Cap5.64T
P/E (TTM)18.52
Forward P/E0.00
EPS1,976.40
Dividend Yield1.64%
Beta0.42
50-Day Avg37,366.00
200-Day Avg46,790.50

About

Imexpharm Corporation operates as a pharmaceutical company in Vietnam. The company's products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, analgesic - anti-inflammatory - antipyretics, respiratory system, antihistamines and anti-allergy, central nervous system, digestive system, diabetes, anti-parasitic, external drugs, vitamins and minerals, and supplements. It is also involved in the import and export. Imexpharm Corporation was founded in 1997 and is headquartered in Cao Lanh, Vietnam. As of April 29, 2026, Imexpharm Corporation operates as a subsidiary of Livzon Pharmaceutical Group Inc..

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Dao Thi Tran
  • Employees1.44K
  • HeadquartersNo. 04, 30/04 Street, Cao Lanh, Vietnam, Vietnam
  • Websitehttps://www.imexpharm.com

Leadership

  • Ms. Dao Thi TranGeneral Director, Member of Executive Board & Director · b. 1952
  • Mr. Tuan Minh NgoDeputy General Director, COO & Member of Executive Board · b. 1979
  • Mr. Nhung Van HuynhDeputy General Director, Chief Quality Officer & Member of Executive Board · b. 1973
  • Mr. Phuong Van Nha LeDeputy General Director, Chief Production Officer & Member of Executive Board · b. 1980
  • Ms. Hoai Nu Minh LeDeputy General Director, Chief Commercial Officer & Member of Executive Board · b. 1966
  • Mr. Vu Hoang DuongChief Accountant · b. 1982
  • Ms. Le Thi Kim NguyenSecretary of the Board of Directors · b. 1983

Financials

Income Statement

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.40T1.37T1.27T1.64T1.99T2.21T2.44T
Growth (%)--2.36%-7.51%+29.77%+21.31%+10.59%+10.70%
Cost of Revenue874.53B822.38B778.60B946.35B1.18T1.35T1.44T
Gross Profit527.92B547.05B488.00B697.36B810.54B855.56B1.00T
Gross Margin37.64%39.95%38.53%42.43%40.65%38.80%41.03%
Operating Expense324.88B284.49B253.93B400.86B429.49B440.30B539.13B
Operating Income203.04B262.55B234.07B296.50B381.04B415.26B462.44B
Operating Margin14.48%19.17%18.48%18.04%19.11%18.83%18.94%
EBITDA247.37B314.21B304.77B355.58B465.95B513.32B567.47B
EBITDA Margin17.64%22.94%24.06%21.63%23.37%23.28%23.25%
Net Income162.39B209.70B189.09B223.54B299.56B320.86B349.14B
Net Income Margin11.58%15.31%14.93%13.60%15.02%14.55%14.30%
R&D53.59B------
R&D as % of Total Revenue3.82%------
Interest Expense3.73B5.41B5.50B3.79B6.04B3.49B16.50B
Interest Expense % of Total Revenue0.27%0.39%0.43%0.23%0.30%0.16%0.68%

Balance Sheet

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.85T2.10T2.29T2.28T2.39T2.50T2.78T
Total Liabilities288.29B365.97B500.29B382.50B308.04B321.66B476.11B
Total Equity1.56T1.73T1.79T1.89T2.08T2.18T2.31T
Cash75.04B85.27B271.27B178.85B106.20B161.98B189.19B
Net Debt-45.66B----23.59B

Cash Flow

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow66.59B73.15B234.88B378.60B-40.47B216.27B54.17B
Investing Cash Flow-120.62B-136.48B-83.14B-199.30B---
Financing Cash Flow-61.36B73.59B34.50B-271.72B---
Capital Expenditure131.12B89.68B52.86B99.35B63.09B96.77B26.88B
Free Cash Flow-64.53B-16.53B182.02B279.25B-103.57B119.50B27.29B
Dividends Paid98.80B49.39B100.01B100.01B66.67B70.00B77.00B
FCF to OCF-96.91%-22.60%77.50%73.76%255.90%55.25%50.38%
Dividend Paid to FCF-153.10%-298.75%54.94%35.81%-64.38%58.58%282.15%

Earnings

Report DateDec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Mar 1, 2017May 31, 2017Aug 30, 2017Nov 29, 2017Feb 28, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023Jul 18, 2023Oct 18, 2023Jan 19, 2024May 29, 2024Jul 22, 2024Oct 18, 2024Jan 20, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------
EPS Actual384.74633.51619.78601.61-17.39220.90654.59638.89630.48225.40707.06385.27565.04156.48153.46175.99323.61181.65594.59172.73168.66195.03184.27209.65251.50215.45193.46246.33308.16243.89280.72301.98406.75266.25281.83178.95300.56266.34371.61406.47444.69424.57384.71469.77341.74428.01435.98783.13448.34471.68429.37697.94474.46543.34
Surprise------------------------------------------------------
Timing-----------------------------------------Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market------

Key Statistics & Ratios

Market Cap5.64T
Enterprise Value5.39T
Trailing P/E18.52
Forward P/E0.00
Price / Sales2.43
Price / Book2.43
EPS1,976.40
Book Value15,200.82
Revenue (TTM)2.32T
Gross Profit (TTM)1.11T
EBITDA568.40B
Profit Margin15.51%
Operating Margin20.85%
Return on Equity16.15%
Return on Assets9.78%
Shares Outstanding154.01M
Shares Float1.48M
Beta0.42
Dividend Yield1.64%
Dividend Rate600.00
Payout Ratio27.97%

Dividends

20261×
600.00Jul 13, 2026
20251×
500.00Jun 9, 2025
20241×
500.00Jul 11, 2024
20232×
454.55Oct 5, 20231000.00Sep 7, 2023
20221×
649.35May 25, 2022
20211×
649.35Jun 23, 2021
20201×
432.90Jul 14, 2020
20191×
666.00Jun 13, 2019
20172×
144.78Nov 28, 2017231.65May 24, 2017
20161×
501.93May 19, 2016
20151×
451.73May 15, 2015
20141×
250.96May 15, 2014
20132×
167.31Nov 14, 2013167.31Jun 5, 2013
20122×
200.77Oct 16, 2012334.62Apr 25, 2012
20111×
334.62May 5, 2011
20101×
269.85Apr 14, 2010
20091×
134.93Apr 27, 2009
20081×
134.93Nov 10, 2008

Stock Splits

  • Sep 17, 20242:1
  • Jul 11, 202411:10
  • Oct 5, 202321:20
  • Jul 14, 202013:10
  • Jun 4, 201823:20
  • May 24, 201711:10
  • Dec 16, 20161222:1165
  • Aug 27, 2014479156:319437
  • Oct 16, 201211:10
  • Dec 29, 201062:55